ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 5.94
-0.17 (-2.78%)
Apr 17, 2026, 4:08 PM HKT
HKG:1541 Market Cap
HKG:1541 has a market cap or net worth of 2.64 billion as of April 17, 2026. Its market cap has increased by 37.43% in one year.
Market Cap
2.64B
Enterprise Value
1.76B
Revenue
171.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.94
Market Cap Chart
Since September 5, 2023, HKG:1541's market cap has decreased from 7.29B to 2.64B, a decrease of -63.81%. That is a compound annual growth rate of -32.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 2.64B | 4.80% |
| Dec 31, 2025 | 2.52B | 19.70% |
| Dec 31, 2024 | 2.10B | -81.21% |
| Dec 29, 2023 | 11.19B | 53.55% |
| Sep 5, 2023 | 7.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Clover Biopharmaceuticals | 3.79B |
| BioDlink International Company | 3.78B |
| AIM Vaccine | 3.73B |
| Mirxes Holding Company | 3.66B |
| Jiangsu Recbio Technology | 3.15B |
| Medtide | 3.13B |
| SinoMab BioScience | 2.34B |
| Immunotech Biopharm | 2.24B |